Suppr超能文献

pT3期肾细胞癌患者的癌症特异性生存率——2002年原发性肿瘤分类能否得到改进?

Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?

作者信息

Leibovich Bradley C, Cheville John C, Lohse Christine M, Zincke Horst, Kwon Eugene D, Frank Igor, Thompson R Houston, Blute Michael L

机构信息

Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

J Urol. 2005 Mar;173(3):716-9. doi: 10.1097/01.ju.0000151830.27750.d2.

Abstract

PURPOSE

The 2002 primary tumor classification for renal cell carcinoma (RCC) does not distinguish between patients with tumor thrombus involving the renal vein only and those with inferior vena cava tumor thrombus below the diaphragm. We evaluated the association of tumor thrombus level and fat invasion with outcome to determine if further subclassification would improve the prognostic accuracy of the current classification.

MATERIALS AND METHODS

We studied 675 patients treated with radical nephrectomy or nephron sparing surgery for pT3a (206, 30.5%), pT3b (422, 62.5%), pT3c (19, 2.8%) or pT4 (28, 4.2%) RCC at the Mayo Clinic between 1970 and 2000. Associations with outcome were evaluated using Cox proportional hazards regression.

RESULTS

There were 531 deaths from RCC at a median of 1.5 years following nephrectomy. Patients with pT3b RCC and level I, II or III tumor thrombus were significantly more likely to die of RCC compared to patients with pT3b RCC and level 0 tumor thrombus (risk ratio 1.62, p <0.001). Patients with peripheral perinephric or renal sinus fat invasion were also more likely to die of RCC compared to patients without fat invasion (risk ratio 1.87, p <0.001). Therefore, patients with pT3 RCC were reclassified into 4 groups as thrombus level 0 without fat invasion, fat invasion only, thrombus level 0 with fat invasion or thrombus level I, II or III without fat invasion, and thrombus level I, II or III with fat invasion or thrombus level IV. This reclassification significantly improved prediction of death from RCC compared with the current classification (c indexes of 0.61 versus 0.55, respectively).

CONCLUSIONS

Further subclassification of the primary tumor classification for patients with pT3 RCC improved prognostic accuracy.

摘要

目的

2002年肾细胞癌(RCC)的原发性肿瘤分类未区分仅累及肾静脉的肿瘤血栓患者与膈下下腔静脉肿瘤血栓患者。我们评估了肿瘤血栓水平和脂肪浸润与预后的相关性,以确定进一步细分是否会提高当前分类的预后准确性。

材料与方法

我们研究了1970年至2000年间在梅奥诊所接受根治性肾切除术或保留肾单位手术治疗的675例pT3a(206例,30.5%)、pT3b(422例,62.5%)、pT3c(19例,2.8%)或pT4(28例,4.2%)RCC患者。使用Cox比例风险回归评估与预后的相关性。

结果

肾切除术后中位1.5年时有531例患者死于RCC。与pT3b RCC且肿瘤血栓水平为0的患者相比,pT3b RCC且肿瘤血栓水平为I、II或III的患者死于RCC的可能性显著更高(风险比1.62,p<0.001)。与无脂肪浸润的患者相比,有肾周或肾窦周围脂肪浸润的患者死于RCC的可能性也更高(风险比1.87,p<0.001)。因此,将pT3 RCC患者重新分为4组:无脂肪浸润的血栓水平0组、仅脂肪浸润组、有脂肪浸润的血栓水平0组或无脂肪浸润的血栓水平I、II或III组,以及有脂肪浸润的血栓水平I、II或III组或血栓水平IV组。与当前分类相比,这种重新分类显著改善了对RCC死亡的预测(c指数分别为0.61和0.55)。

结论

对pT3 RCC患者的原发性肿瘤分类进行进一步细分提高了预后准确性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验